Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1973 1
1975 1
1979 1
1983 1
1989 1
1991 1
1992 1
1997 1
1998 1
1999 2
2000 2
2001 3
2002 2
2003 3
2004 7
2005 1
2006 1
2007 4
2008 5
2009 6
2010 14
2011 10
2012 12
2013 14
2014 19
2015 14
2016 15
2017 16
2018 24
2019 34
2020 44
2021 54
2022 54
2023 42
2024 77
2025 80
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

528 results

Results by year

Filters applied: . Clear all
Page 1
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD; endTB Clinical Trial Team. Guglielmetti L, et al. N Engl J Med. 2025 Jan 30;392(5):468-482. doi: 10.1056/NEJMoa2400327. N Engl J Med. 2025. PMID: 39879593 Free PMC article. Clinical Trial.
METHODS: We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for treatment of fluoroquinolone-susceptible, rifampin-resistant tuberculosis with five 9-month oral regimens that included various combinations of …
METHODS: We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for trea …
Literature Commentary.
[No authors listed] [No authors listed] J Neuroophthalmol. 2024 Dec 1;44(4):587-592. doi: 10.1097/WNO.0000000000002285. J Neuroophthalmol. 2024. PMID: 40418702
Ophthalmology. 2024;131:724-730.4. Hathaway JT, Shah M, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr, Cestari D, Mallery R, Abbasi B, Bouffard M, Chwalisz BK, Estrela T, Rizzo JF III. ...
Ophthalmology. 2024;131:724-730.4. Hathaway JT, Shah M, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr, Cestari D, Mallery R, …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2025 May;15(2_suppl):793S-822S. doi: 10.1177/21925682251336882. Epub 2025 May 21. Global Spine J. 2025. PMID: 40397527 Free PMC article. No abstract available.
Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology.
Wu Y, Ehlert B, Metwally AA, Perelman D, Park H, Brooks AW, Abbasi F, Michael B, Celli A, Bejikian C, Ayhan E, Lu Y, Lancaster SM, Hornburg D, Ramirez L, Bogumil D, Pollock S, Wong F, Bradley D, Gutjahr G, Rangan ES, Wang T, McGuire L, Venkat Rangan P, Ræder H, Shipony Z, Lipson D, McLaughlin T, Snyder MP. Wu Y, et al. Nat Med. 2025 Jul;31(7):2232-2243. doi: 10.1038/s41591-025-03719-2. Epub 2025 Jun 4. Nat Med. 2025. PMID: 40467897 Free PMC article.
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.
Koprulu M, Smith-Byrne K, Ferolito BR, Macdonald-Dunlop E, Luan J, Hedman ÅK, Ogamba CF, Kuliesius J, Repetto L, Ramisch A, Abbasi F, Ärnlöv J, Assimes TL; BeLOVE Study Group; Björck HM, Björkander S, Böttcher M, Butterworth AS, Chen Z, Cho K, Clarke RJ, Cox SR, Czene K, Danesh J, Dedoussis G, Elmståhl S, Eriksson N, Eriksson P, Esko T; Estonian Biobank Research Team; Ferreiro-Iglesias A, Franks PW, Fu J, Gaziano JM, Ghanbari M, Gieger C, Gilly A, Grallert H, Gunter MJ, Gustafsson S, Göteson A, Hall PFL, Hansson O, Harris SE, Hayward C, Herder C, Hernandez-Pacheco N, Hijazi Z, Hillary RF, Hopewell JC, Hu S, Hwang SJ, Jern C, Johansson Å, Jonsson L, Kalnapenkis A, Kerrison ND, Kho PF, Klaric L, Kohleick L, Kraft J, Landén M, Levy D, Li L, Lind L, Long J, Mattsson-Carlgren N, Melén E, Merid SK, Mertins P, Michaëlsson K, Møller PL, Murgia F, Nyegaard M, Park YC, Pearson E, Peters J, Petrie JR, Png G, Polašek O, Prins BP, Ripke S, Roden M, Rohde PD, Said S; SCALLOP Consortium; Shen X, Schwenk JM, Siegbahn A, Smith JG, Stanne TM, Suhre K, Sundström J, Thorand B, Valdes-Marquez E, Vallerga CL, van Meurs JBJ, Viñuela A, Võsa U, Wallentin L, Walters RG, Wareham NJ, Weber JE, Weersma RK, W… See abstract for full author list ➔ Koprulu M, et al. Cell. 2026 May 28;189(11):3339-3357.e11. doi: 10.1016/j.cell.2026.03.049. Epub 2026 May 6. Cell. 2026. PMID: 42097137 Free PMC article.
Phenotypic approaches for CNS drugs.
Sharma R, Oyagawa CRM, Abbasi H, Dragunow M, Conole D. Sharma R, et al. Trends Pharmacol Sci. 2024 Nov;45(11):997-1017. doi: 10.1016/j.tips.2024.09.003. Epub 2024 Oct 21. Trends Pharmacol Sci. 2024. PMID: 39438155 Free article. Review.
528 results